Plant ID: NPO7697
Plant Latin Name: Asimina Triloba
Taxonomy Genus: Asimina
Taxonomy Family: Annonaceae
NCBI TaxonomyDB:
12953
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC97028
Ingredient ID: NPC93794
Ingredient ID: NPC90859
Ingredient ID: NPC81778
Ingredient ID: NPC66288
Ingredient ID: NPC480253
Ingredient ID: NPC480252
Ingredient ID: NPC480220
Ingredient ID: NPC475232
Ingredient ID: NPC474100
Ingredient ID: NPC473504
Ingredient ID: NPC37669
Ingredient ID: NPC331654
Ingredient ID: NPC331613
Ingredient ID: NPC320569
Ingredient ID: NPC318591
Ingredient ID: NPC294965
Ingredient ID: NPC279450
Ingredient ID: NPC274446
Ingredient ID: NPC270837
Ingredient ID: NPC25703
Ingredient ID: NPC256849
Ingredient ID: NPC24101
Ingredient ID: NPC239517
Ingredient ID: NPC234077
Ingredient ID: NPC22005
Ingredient ID: NPC198418
Ingredient ID: NPC161423
Ingredient ID: NPC142117
Ingredient ID: NPC12609
Ingredient ID: NPC110710
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Therapeutic Target | Enzyme | ATIC | AICAR transformylase | P31939 | CHEMBL2518 |
Therapeutic Target | Metallo protease | METAP2 | Methionine aminopeptidase 2 | P50579 | CHEMBL3922 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | NR3C2 | Mineralocorticoid receptor | P08235 | CHEMBL1994 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | AR | Androgen Receptor | P10275 | CHEMBL1871 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | PGR | Progesterone receptor | P06401 | CHEMBL208 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | NR3C1 | Glucocorticoid receptor | P04150 | CHEMBL2034 |
Therapeutic Target | Oxidoreductase | DHFR | Dihydrofolate reductase | P00374 | CHEMBL202 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Protein Kinase | HIPK1 | Homeodomain-interacting protein kinase 1 | Q86Z02 | CHEMBL5427 |
Therapeutic Target | Protein Kinase | BRAF | Serine/threonine-protein kinase B-raf | P15056 | CHEMBL5145 |
Therapeutic Target | Protein Kinase | PDGFRB | Platelet-derived growth factor receptor beta | P09619 | CHEMBL1913 |
Therapeutic Target | Protein Kinase | RET | Tyrosine-protein kinase receptor RET | P07949 | CHEMBL2041 |
Therapeutic Target | Protein Kinase | FLT1 | Vascular endothelial growth factor receptor 1 | P17948 | CHEMBL1868 |
Therapeutic Target | Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Therapeutic Target | Protein Kinase | FGFR1 | Fibroblast growth factor receptor 1 | P11362 | CHEMBL3650 |
Therapeutic Target | Protein Kinase | KIT | Stem cell growth factor receptor | P10721 | CHEMBL1936 |
Therapeutic Target | Protein Kinase | MAPK3 | MAP kinase ERK1 | P27361 | CHEMBL3385 |
Therapeutic Target | Protein Kinase | CSNK1A1 | Casein kinase I alpha | P48729 | CHEMBL2793 |
Therapeutic Target | Protein Kinase | ABL1 | Tyrosine-protein kinase ABL | P00519 | CHEMBL1862 |
Therapeutic Target | Protein Kinase | CDK8 | Cell division protein kinase 8 | P49336 | CHEMBL5719 |
Therapeutic Target | Protein Kinase | FLT4 | Vascular endothelial growth factor receptor 3 | P35916 | CHEMBL1955 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | CDK19 | Cell division cycle 2-like protein kinase 6 | Q9BWU1 | CHEMBL6002 |
Therapeutic Target | Protein Kinase | DDR2 | Discoidin domain-containing receptor 2 | Q16832 | CHEMBL5122 |
Therapeutic Target | Protein Kinase | SRC | Tyrosine-protein kinase SRC | P12931 | CHEMBL267 |
Therapeutic Target | Protein Kinase | TEK | Tyrosine-protein kinase TIE-2 | Q02763 | CHEMBL4128 |
Therapeutic Target | Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Therapeutic Target | Protein Kinase | RAF1 | Serine/threonine-protein kinase RAF | P04049 | CHEMBL1906 |
Therapeutic Target | Protein Kinase | EPHB4 | Ephrin type-B receptor 4 | P54760 | CHEMBL5147 |
Therapeutic Target | Protein Kinase | CDK6 | Cyclin-dependent kinase 6 | Q00534 | CHEMBL2508 |
Therapeutic Target | Protein Kinase | HIPK4 | Homeodomain-interacting protein kinase 4 | Q8NE63 | CHEMBL1075167 |
Therapeutic Target | Protein Kinase | HIPK3 | Homeodomain-interacting protein kinase 3 | Q9H422 | CHEMBL4577 |
Therapeutic Target | Protein Kinase | LCK | Tyrosine-protein kinase LCK | P06239 | CHEMBL258 |
Therapeutic Target | Protein Kinase | PDGFRA | Platelet-derived growth factor receptor alpha | P16234 | CHEMBL2007 |
Therapeutic Target | Protein Kinase | HCK | Tyrosine-protein kinase HCK | P08631 | CHEMBL3234 |
Therapeutic Target | Protein Kinase | CSF1R | Macrophage colony stimulating factor receptor | P07333 | CHEMBL1844 |
Therapeutic Target | Protein Kinase | MAPK14 | MAP kinase p38 alpha | Q16539 | CHEMBL260 |
Therapeutic Target | Protein Kinase | HIPK2 | Homeodomain-interacting protein kinase 2 | Q9H2X6 | CHEMBL4576 |
Therapeutic Target | Protein Kinase | MKNK2 | MAP kinase signal-integrating kinase 2 | Q9HBH9 | CHEMBL4204 |
Therapeutic Target | Secreted protein | SHBG | Testis-specific androgen-binding protein | P04278 | CHEMBL3305 |
Therapeutic Target | Secreted protein | SERPINA6 | Corticosteroid binding globulin | P08185 | CHEMBL2421 |
Therapeutic Target | Serine protease | EPHX2 | Epoxide hydratase | P34913 | CHEMBL2409 |
Drug Transporter | SLC superfamily of solute carriers | SLC19A1 | Folate transporter 1 | P41440 | CHEMBL4833 |
Drug Transporter | SLC superfamily of solute carriers | SLC6A4 | Serotonin transporter | P31645 | CHEMBL228 |
Therapeutic Target | Small molecule receptor (family A GPCR) | HTR2B | Serotonin 2b (5-HT2b) receptor | P41595 | CHEMBL1833 |
Therapeutic Target | Small molecule receptor (family A GPCR) | HTR2C | Serotonin 2c (5-HT2c) receptor | P28335 | CHEMBL225 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRB1 | Beta-1 adrenergic receptor | P08588 | CHEMBL213 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRB2 | Beta-2 adrenergic receptor | P07550 | CHEMBL210 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRB3 | Beta-3 adrenergic receptor | P13945 | CHEMBL246 |
Drug Transporter | Voltage-gated calcium channel | CACNA1C | Voltage-gated L-type calcium channel alpha-1C subunit | Q13936 | CHEMBL1940 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 317 | |
Plant level | 1 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00611871 | The Use of Propranolol to Block Memory Reconsolidation in PTSD | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT00254553 | A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815) | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03091348 | Subcutaneous vs. Intramuscular Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00673309 | Assessment of Mechanisms of Improved Wound Healing | burn | Propranolol (NPC318591) | NP level |
NCT00465608 | Propranolol in Post Traumatic Stress Disorder | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT01629329 | Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine | migraine disorder | Caffeine (NPC256849) | NP level |
NCT01652040 | Resistance Training and Testosterone After Spinal Cord Injury | Spinal cord injury | Testosterone (NPC161423) | NP level |
NCT02990533 | Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients | aging | Testosterone (NPC161423) | NP level |
NCT00962637 | Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT02985671 | To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain. | Low back pain | Caffeine (NPC256849) | NP level |
NCT00183040 | HORMA: Hormonal Regulators of Muscle and Metabolism in Aging | sarcopenia | Testosterone (NPC161423) | NP level |
NCT02419105 | Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01364623 | PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01902810 | Protective Effects of Propranolol in Adults | burn | Propranolol (NPC318591) | NP level |
NCT03609307 | Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial | age-related macular degeneration | Propranolol (NPC318591) | NP level |
NCT02620579 | Biopsychosocial Influence on Shoulder Pain | Shoulder pain | Propranolol (NPC318591) | NP level |
NCT02962947 | MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients | melanoma | Propranolol (NPC318591) | NP level |
NCT03321734 | Intermittent Hypoxia and Caffeine in Infants Born Preterm | hypoxia | Caffeine (NPC256849) | NP level |
NCT02149264 | A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00390546 | Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia | Supraventricular tachycardia | Propranolol (NPC318591) | NP level |
NCT00432887 | Experimental Studies of the Effects of Caffeine on Glucose Regulation | type 2 diabetes mellitus | Caffeine (NPC256849) | NP level |
NCT00331214 | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01349439 | Reducing Reconsolidation of Trauma Memories With Propranolol | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT02111434 | Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04005365 | Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer | gastric cancer | Propranolol (NPC318591) | NP level |
NCT00093860 | Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance | Syncope | Propranolol (NPC318591) | NP level |
NCT00916721 | Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence | smoking cessation | Propranolol (NPC318591) | NP level |
NCT01743235 | Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT04872270 | Pain Management After Shoulder Arthroplasty | pain | Caffeine (NPC256849) | NP level |
NCT00772031 | NINDS CRC Chronic Migraine Treatment Trial | migraine disorder | Propranolol (NPC318591) | NP level |
NCT04985344 | Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT00413244 | The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery | coronary artery disease | Testosterone (NPC161423) | NP level |
NCT02862977 | Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine and Caffeine in Osteomuscular Treatment | pain | Caffeine (NPC256849) | NP level |
NCT02582996 | Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks | migraine disorder | Caffeine (NPC256849) | NP level |
NCT02504944 | Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) | retinopathy of prematurity | Propranolol (NPC318591) | NP level |
NCT03131973 | Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin | rheumatoid arthritis | Caffeine (NPC256849) | NP level |
NCT01007084 | TRAUMA HELP: Healing and Analgesia With Propranolol | injury | Propranolol (NPC318591) | NP level |
NCT03919461 | Colorectal Metastasis Prevention International Trial 2 | colorectal neoplasm | Propranolol (NPC318591) | NP level |
NCT04982211 | Comparing Standard vs. Modified Reconsolidation Blockade for the Treatment of Psychological Trauma | acute stress reaction;post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT01786473 | Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01822587 | Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving | cocaine dependence | Propranolol (NPC318591) | NP level |
NCT02649335 | To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites | Ascites | Propranolol (NPC318591) | NP level |
NCT01705392 | Bevacizumab vs Dacarbazine in Metastatic Melanoma | melanoma | Propranolol (NPC318591) | NP level |
NCT00161421 | Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00000493 | Multicenter Investigation of Limitation of Infarct Size (MILIS) | myocardial infarction;Myocardial Ischemia | Propranolol (NPC318591) | NP level |
NCT01462370 | Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1) | Dysmenorrhea | Caffeine (NPC256849) | NP level |
NCT00467259 | Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02505971 | Nadolol Versus Propranolol in Children With Infantile Hemangiomas | hemangioma | Propranolol (NPC318591) | NP level |
NCT00549120 | Optimising the Propranolol Block Model | chronic obstructive pulmonary disease | Propranolol (NPC318591) | NP level |
NCT03003000 | Ibuprofen/Caffeine Lower Back or Neck Pain Study | Back pain;Neck pain | Caffeine (NPC256849) | NP level |
NCT02511483 | Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain | pain | Propranolol (NPC318591) | NP level |
NCT04976595 | Vogelxo(R) ABPM Study in Hypogandal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00889096 | Effects of Propranolol on the Encoding and Retrieval of Emotional Material After Single Dose Administration in Healthy Young Subjects | memory impairment | Propranolol (NPC318591) | NP level |
NCT01993212 | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT02256865 | Hormonal Mechanisms of Sleep Restriction | insulin resistance | Testosterone (NPC161423) | NP level |
NCT03323710 | Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma | renal cell carcinoma | Propranolol (NPC318591) | NP level |
NCT01386606 | The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT01252745 | Efficacy of an Intranasal Testosterone Product | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04523480 | Vitality | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00471952 | Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache | migraine with aura;migraine without aura | Caffeine (NPC256849) | NP level |
NCT01616732 | Testosterone and Weight Loss | obesity | Testosterone (NPC161423) | NP level |
NCT03588754 | Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking? | alcohol drinking | Propranolol (NPC318591) | NP level |
NCT00382057 | Testosterone Effects on Men With the Metabolic Syndrome | metabolic syndrome | Testosterone (NPC161423) | NP level |
NCT05445232 | A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants | obesity | Caffeine (NPC256849) | NP level |
NCT04570085 | Effect of CAFfeine on Cognition in Alzheimer's Disease | Alzheimer disease | Caffeine (NPC256849) | NP level |
NCT01370369 | Efficacy, Pharmacokinetics and Safety of Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00431197 | Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03118479 | Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) | Kallmann syndrome | Testosterone (NPC161423) | NP level |
NCT01636557 | A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Caffeine (NPC256849) | NP level |
NCT00202163 | ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction | erectile dysfunction | Testosterone (NPC161423) | NP level |
NCT00692510 | Drug Interaction Study Between AZD3480 and Cytochrome P450 | Alzheimer disease | Caffeine (NPC256849) | NP level |
NCT01007994 | Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients | hypertension | Propranolol (NPC318591) | NP level |
NCT00400335 | Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01875159 | Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm | hypoxia | Caffeine (NPC256849) | NP level |
NCT02317640 | TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males | Spinal cord injury | Testosterone (NPC161423) | NP level |
NCT01755702 | Paracetamol With Caffeine to Treat Episodic Tension Type Headache | Tension-type headache | Caffeine (NPC256849) | NP level |
NCT03345797 | Evaluation of Testosterone Nasal Gel in Hypogonadal Boys | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04492553 | Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00857454 | A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00433199 | Testosterone Treatment for Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00884663 | Candesartan Versus Propranolol for Migraine Prevention | migraine with aura;migraine without aura | Propranolol (NPC318591) | NP level |
NCT01957449 | Propranolol in Severely Burned Children | burn | Propranolol (NPC318591) | NP level |
NCT01432665 | Lybrido for Female Sexual Dysfunction | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT03029845 | Propranolol for Treating Fibromyalgia Pain | fibromyalgia | Propranolol (NPC318591) | NP level |
NCT00757185 | Compromised Microcirculation in Women With Polycystic Ovary Syndrome | polycystic ovary syndrome | Testosterone (NPC161423) | NP level |
NCT02153944 | Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety | anxiety | Propranolol (NPC318591) | NP level |
NCT00586898 | Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | prostate carcinoma | Testosterone (NPC161423) | NP level |
NCT00377975 | "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat | obesity | Caffeine (NPC256849) | NP level |
NCT05427474 | Role of Combined Therapy of Propranolol and Gabapentin in Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury | brain injury | Propranolol (NPC318591) | NP level |
NCT03000127 | Testosterone for Fatigue in Men With MS | multiple sclerosis | Testosterone (NPC161423) | NP level |
NCT01713556 | Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT02467400 | Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism | osteoporosis | Propranolol (NPC318591) | NP level |
NCT01127659 | Testosterone Replacement in Men With Diabetes and Obesity | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00204269 | Three-Year Trial on a New Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00687700 | A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers | chronic obstructive pulmonary disease | Propranolol (NPC318591) | NP level |
NCT02048215 | Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity | obesity | Caffeine (NPC256849) | NP level |
NCT03187496 | Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. | non-alcoholic steatohepatitis | Caffeine (NPC256849) | NP level |
NCT04439799 | A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04274894 | A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01525628 | Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients | chronic hepatitis C virus infection | Caffeine (NPC256849) | NP level |
NCT00000197 | Propranolol for Treatment of Cocaine Addiction - 2 | cocaine dependence | Propranolol (NPC318591) | NP level |
NCT05011383 | High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers | metastatic prostate cancer | Testosterone (NPC161423) | NP level |
NCT03333824 | Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer | neoplasm | Caffeine (NPC256849) | NP level |
NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | atopic eczema | Caffeine (NPC256849) | NP level |
NCT01134692 | Probiotics for Portal Hypertension | cirrhosis of liver;esophageal varices | Propranolol (NPC318591) | NP level |
NCT01202110 | Early Propranolol After Traumatic Brain Injury: Phase II | brain injury | Propranolol (NPC318591) | NP level |
NCT04113187 | Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients | hereditary hemorrhagic telangiectasia | Propranolol (NPC318591) | NP level |
NCT03237637 | Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas | hemangioma | Propranolol (NPC318591) | NP level |
NCT02420223 | Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients | multiple myeloma | Propranolol (NPC318591) | NP level |
NCT02679274 | Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents | aging | Testosterone (NPC161423) | NP level |
NCT03345576 | Testosterone and Long Pulse Stimulation After SCI | Spinal cord injury | Testosterone (NPC161423) | NP level |
NCT02596867 | Neoadjuvant Propanolol in Breast Cancer | breast cancer | Propranolol (NPC318591) | NP level |
NCT01517399 | Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects | neoplasm | Caffeine (NPC256849) | NP level |
NCT01235754 | Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01634347 | Memory Reconsolidation Blockade for Treating Drug Addiction | substance dependence | Propranolol (NPC318591) | NP level |
NCT02647086 | Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD) | atopic eczema | Caffeine (NPC256849) | NP level |
NCT01160328 | Influence of Male Hormones on Regional Fat Metabolism | obesity | Testosterone (NPC161423) | NP level |
NCT00384046 | Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT03358706 | A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis | Crohn's disease;ulcerative colitis | Caffeine (NPC256849) | NP level |
NCT00069355 | Propranolol for the Treatment of Acute Stress Disorder | injury | Propranolol (NPC318591) | NP level |
NCT00698035 | Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT03838029 | Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery | pancreatic neoplasm | Propranolol (NPC318591) | NP level |
NCT02832336 | The Effect of Caffeine on the Narcoleptic Patients | narcolepsy | Caffeine (NPC256849) | NP level |
NCT01074437 | Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) | hemangioma | Propranolol (NPC318591) | NP level |
NCT01275170 | A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005) | infectious disease | Caffeine (NPC256849) | NP level |
NCT01797718 | Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment | Growth delay | Testosterone (NPC161423) | NP level |
NCT00479609 | Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes | metabolic syndrome | Testosterone (NPC161423) | NP level |
NCT00398580 | 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03198728 | Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02418065 | Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO) | chronic kidney disease | Testosterone (NPC161423) | NP level |
NCT03734653 | Testosterone Therapy in Castration Resistant Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT04741698 | Propranolol for Protracted Labor | dystocia | Propranolol (NPC318591) | NP level |
NCT05189977 | A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT00140153 | Testosterone in Female Hypoactive Sexual Desire Disorder | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02111473 | The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01127568 | A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT01419236 | A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00965341 | Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | cancer | Testosterone (NPC161423) | NP level |
NCT04580342 | Ivabradine Versus Propranolol for Induced Hypotension in Endoscopic Sinus Surgery | hypotension | Propranolol (NPC318591) | NP level |
NCT01270841 | Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT02317263 | A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis | multiple sclerosis | Testosterone (NPC161423) | NP level |
NCT03970798 | A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin | Parkinson disease | Caffeine (NPC256849) | NP level |
NCT02445716 | Transdermal Testosterone Nanoemulsion in Women Libido | menopause | Testosterone (NPC161423) | NP level |
NCT00345969 | Exercise and Testosterone Therapy in Elderly Men With Physical Frailty | hip fracture;hypogonadism | Testosterone (NPC161423) | NP level |
NCT01096329 | A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT04132336 | Study to Find Out the Optimal Dose of Caffeine in the Combination Tablet of Naproxen Sodium and Caffeine in Patients Experiencing Moderate to Severe Pain After Having Wisdom Teeth Removed | pain | Caffeine (NPC256849) | NP level |
NCT04425902 | Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults | HIV infection | Caffeine (NPC256849) | NP level |
NCT01446042 | Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00338312 | Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02081300 | Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01544634 | Beta Blocker Therapy in Mild to Moderate Asthmatics | asthma | Propranolol (NPC318591) | NP level |
NCT03038295 | a Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity | retinopathy of prematurity | Propranolol (NPC318591) | NP level |
NCT00888797 | β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence | colorectal neoplasm | Propranolol (NPC318591) | NP level |
NCT03022838 | The Effects of Caffeine Withdrawal on Migraine | migraine disorder | Caffeine (NPC256849) | NP level |
NCT02183688 | Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients | migraine disorder | Caffeine (NPC256849) | NP level |
NCT02342275 | Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma | hemangioma | Propranolol (NPC318591) | NP level |
NCT01426971 | Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine. | pain | Caffeine (NPC256849) | NP level |
NCT00613002 | Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02772601 | This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis | psoriasis | Caffeine (NPC256849) | NP level |
NCT00651235 | A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome | Marfan syndrome | Propranolol (NPC318591) | NP level |
NCT00405353 | Testosterone Treatment for Multiple Sclerosis | multiple sclerosis | Testosterone (NPC161423) | NP level |
NCT01248468 | Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine | migraine disorder | Caffeine (NPC256849) | NP level |
NCT02203656 | Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults | aging | Testosterone (NPC161423) | NP level |
NCT03281187 | Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men. | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00587431 | Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT02732678 | Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) | angiosarcoma | Propranolol (NPC318591) | NP level |
NCT00244023 | Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone | erectile dysfunction;hypogonadism | Testosterone (NPC161423) | NP level |
NCT00438321 | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome | metabolic syndrome | Testosterone (NPC161423) | NP level |
NCT03533556 | Effects of L-theanine and Caffeine on Attention and Attention-related Brain Activity of Children With Attention Deficit Hyperactivity Disorder | attention deficit hyperactivity disorder | Caffeine (NPC256849) | NP level |
NCT02937740 | Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00000492 | Beta-Blocker Heart Attack Trial (BHAT) | myocardial infarction;Myocardial Ischemia;sudden cardiac arrest;ventricular fibrillation | Propranolol (NPC318591) | NP level |
NCT01893281 | The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02740712 | Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | neoplasm | Caffeine (NPC256849) | NP level |
NCT00315913 | Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor | dystocia | Propranolol (NPC318591) | NP level |
NCT02847806 | Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04265053 | Human Cerebral Blood Flow Regulation | cerebral arterial disease | Testosterone (NPC161423) | NP level |
NCT00459420 | Caffeine for Excessive Daytime Somnolence in Parkinson's Disease | Parkinson disease | Caffeine (NPC256849) | NP level |
NCT01058317 | Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis | papilloma | Propranolol (NPC318591) | NP level |
NCT04684667 | ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" | hemangioma | Propranolol (NPC318591) | NP level |
NCT00522431 | A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03079921 | Adrenergic System in Islet Transplantation | Hypoglycemia | Propranolol (NPC318591) | NP level |
NCT01596647 | Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors | neoplasm | Caffeine (NPC256849) | NP level |
NCT01322048 | DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury | brain injury | Propranolol (NPC318591) | NP level |
NCT01000779 | Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH) | portal hypertension | Propranolol (NPC318591) | NP level |
NCT01263197 | A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol | major depressive disorder | Propranolol (NPC318591) | NP level |
NCT00733993 | Caffeine and Cocaine | cocaine dependence | Caffeine (NPC256849) | NP level |
NCT02722278 | A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | hemangioma | Propranolol (NPC318591) | NP level |
NCT01172405 | Efficacy and Safety Study to Compare Ibuprofen + Caffeine With Ibuprofen Alone in the Treatment of Headache | Headache | Caffeine (NPC256849) | NP level |
NCT00131495 | Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01238471 | Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study | retinopathy of prematurity | Propranolol (NPC318591) | NP level |
NCT01190735 | Caffeine for Motor Manifestations of Parkinson's Disease | Parkinson disease | Caffeine (NPC256849) | NP level |
NCT01978457 | Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction | cocaine dependence | Propranolol (NPC318591) | NP level |
NCT01061190 | Beta Blockers In Acute Ischemic Stroke | stroke | Propranolol (NPC318591) | NP level |
NCT04558567 | Testopel ® vs. Generic Testosterone Pellets. | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02520752 | A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors | neoplasm | Caffeine (NPC256849) | NP level |
NCT00309855 | Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men | aging | Testosterone (NPC161423) | NP level |
NCT01072045 | Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma | hemangioma | Propranolol (NPC318591) | NP level |
NCT03364075 | Genetic Variants Associated With Low Back Pain and Their Response to Treatment With Duloxetine or Propranolol | Low back pain | Propranolol (NPC318591) | NP level |
NCT02311088 | Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor | Dyspnea | Caffeine (NPC256849) | NP level |
NCT01784250 | Efficacy of Clonidine and Propranolol in Dentistry (AAA) | anxiety | Propranolol (NPC318591) | NP level |
NCT00080756 | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease | Hereditary breast and ovarian cancer syndrome | Testosterone (NPC161423) | NP level |
NCT00830362 | Beta-blockade Effects on Memory for Cocaine Craving | cocaine dependence | Propranolol (NPC318591) | NP level |
NCT02873559 | Effect of PROGRESSive Training and Teststerone in Older Frail Men | muscular disease | Testosterone (NPC161423) | NP level |
NCT01323140 | Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00857168 | To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04246762 | Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4 | rheumatoid arthritis | Caffeine (NPC256849) | NP level |
NCT00957528 | Cycled Testosterone Replacement Study | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01512173 | Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | hemangioma | Propranolol (NPC318591) | NP level |
NCT02014454 | Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature | retinopathy of prematurity | Propranolol (NPC318591) | NP level |
NCT00706719 | To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT01080677 | Caffeine/Propranolol Intervention for Acute Migraine | migraine disorder | Propranolol (NPC318591) | NP level |
NCT03378713 | Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM) | infertility | Testosterone (NPC161423) | NP level |
NCT03238092 | Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort | infertility | Testosterone (NPC161423) | NP level |
NCT01205074 | ¹³C-Methacetin Breath Test (MBT) Methodology Study | cirrhosis of liver | Propranolol (NPC318591) | NP level |
NCT01697345 | Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | Dyspareunia | Testosterone (NPC161423) | NP level |
NCT02147964 | ITT-5 Mechanisms of Spermatogenesis in Man | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01665599 | A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01133548 | Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02595996 | Propranolol Dose Escalation in Lymphedema in Patients | lymphedema | Propranolol (NPC318591) | NP level |
NCT03203681 | Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00388128 | Caffeine and Intermittent Claudication | intermittent vascular claudication | Caffeine (NPC256849) | NP level |
NCT04518124 | Propranolol in Angiosarcoma | angiosarcoma | Propranolol (NPC318591) | NP level |
NCT01077921 | Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD) | sickle cell anemia | Propranolol (NPC318591) | NP level |
NCT02323698 | Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury | Spinal cord injury | Caffeine (NPC256849) | NP level |
NCT01435837 | Interaction of Caffeine and Hydration on Voice | voice disorders | Caffeine (NPC256849) | NP level |
NCT00302289 | B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients | obesity | Caffeine (NPC256849) | NP level |
NCT05170464 | The Acute Effects of Exercise and Caffeine on Working Memory During Acute Caffeine Deprivation | memory impairment | Caffeine (NPC256849) | NP level |
NCT00957034 | Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure | heart failure | Testosterone (NPC161423) | NP level |
NCT01080677 | Caffeine/Propranolol Intervention for Acute Migraine | migraine disorder | Caffeine (NPC256849) | NP level |
NCT01462318 | An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis | relapsing-remitting multiple sclerosis | Caffeine (NPC256849) | NP level |
NCT00006158 | AIDS Wasting in Women: Anabolic Effects of Testosterone | AIDS | Testosterone (NPC161423) | NP level |
NCT02631694 | Disruption of Memory Reconsolidating as a Treatment for Panic Disorder | panic disorder | Propranolol (NPC318591) | NP level |
NCT00331123 | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT03151681 | The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT00663793 | ORAL T-6: Oral Androgens in Man-6 | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01738178 | Caffeine as a Therapy for Parkinson's Disease | Parkinson disease | Caffeine (NPC256849) | NP level |
NCT00223691 | Treatment of Orthostatic Hypotension in Autonomic Failure | orthostatic hypotension | Caffeine (NPC256849) | NP level |
NCT01743885 | Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma | hemangioma | Propranolol (NPC318591) | NP level |
NCT02655614 | A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis | amyotrophic lateral sclerosis | Caffeine (NPC256849) | NP level |
NCT01993225 | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT01074853 | Beta Blockers for the Treatment of Asthma | asthma | Propranolol (NPC318591) | NP level |
NCT02712944 | Testosterone Replacement in Renal Failure | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00857961 | A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03161964 | Propranolol in Treating Hypoglycemia Unawareness | type 1 diabetes mellitus | Propranolol (NPC318591) | NP level |
NCT00349791 | Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT02397382 | Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis | psoriasis | Caffeine (NPC256849) | NP level |
NCT00075855 | Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00612742 | Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT01265576 | Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Propranolol (NPC318591) | NP level |
NCT00702650 | A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations | hypogonadism | Testosterone (NPC161423) | NP level |
NCT05485805 | A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo | toothache | Caffeine (NPC256849) | NP level |
NCT00930306 | AZD2066 Cocktail Study | Chronic pain | Caffeine (NPC256849) | NP level |
NCT01847001 | Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | breast cancer | Propranolol (NPC318591) | NP level |
NCT03523650 | Oral Propanolol for Surgically Inaccessible Cavernous Malformations | famililal cerebral cavernous malformations | Propranolol (NPC318591) | NP level |
NCT01887418 | Pharmacokinetic Study of Testosterone Enanthate | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00726726 | Drug Interaction Study With a Potential Alzheimer's Disease Compound | Alzheimer disease | Caffeine (NPC256849) | NP level |
NCT00161486 | The Effects of Testosterone on Prostate Tissue (ACYP-1) | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01087749 | Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers | kidney disease | Propranolol (NPC318591) | NP level |
NCT00372008 | Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00513110 | A Possible Therapeutic Role for Adenosine During Inflammation | serum lipopolysaccharide activity | Caffeine (NPC256849) | NP level |
NCT01228071 | Time to Eugonadal Range, Time to Steady State and Drying Time | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02101203 | Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00437632 | Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809 | substance dependence | Caffeine (NPC256849) | NP level |
NCT01988883 | Modafinil and Cognitive Function in POTS | orthostatic hypotension | Propranolol (NPC318591) | NP level |
NCT02012777 | Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease | sickle cell anemia | Propranolol (NPC318591) | NP level |
NCT00304213 | Does Testosterone Improve Function in Hypogonadal Older Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00647868 | NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02452255 | Fenofibrate and Propranolol in Burn Patients | burn | Propranolol (NPC318591) | NP level |
NCT01842633 | Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache | pain | Caffeine (NPC256849) | NP level |
NCT00967226 | Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas | hemangioma | Propranolol (NPC318591) | NP level |
NCT01289561 | Combined Effects of Alcohol and Caffeine | alcohol dependence | Caffeine (NPC256849) | NP level |
NCT01403116 | Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00657501 | Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women | sexual dysfunction | Testosterone (NPC161423) | NP level |
NCT00495092 | Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients | cocaine dependence | Caffeine (NPC256849) | NP level |
NCT00158132 | Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 | cocaine dependence | Propranolol (NPC318591) | NP level |
NCT00356187 | Beta Blockade in Critical Injury | injury | Propranolol (NPC318591) | NP level |
NCT00688805 | Effects of Propranolol on Responses to Drug-Related Imagery Scripts | cocaine dependence | Propranolol (NPC318591) | NP level |
NCT01816295 | A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00006044 | Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy | prostate cancer | Testosterone (NPC161423) | NP level |
NCT01703741 | A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01686646 | Effects of Two Doses of a Common Cold Treatment on Alertness | common cold | Caffeine (NPC256849) | NP level |
NCT02594358 | Caffeine in Amblyopia Study | amblyopia | Caffeine (NPC256849) | NP level |
NCT02051634 | Papaya Study ID:20140628 | Systemic Inflammation|Aging | Asimina Triloba | Plant level As single plant |
NCT03864042 | Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors | metastatic melanoma | Caffeine (NPC256849) | NP level |
NCT04186286 | Crossover Study of Propranolol vs Ivabradine in POTS | orthostatic hypotension | Propranolol (NPC318591) | NP level |
NCT02871349 | Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response | autism spectrum disorder | Propranolol (NPC318591) | NP level |
NCT03339635 | Short-term Testosterone Replacement in Testicular Cancer Survivors | testicular carcinoma | Testosterone (NPC161423) | NP level |
NCT02110368 | Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions | hypogonadotropic hypogonadism | Testosterone (NPC161423) | NP level |
NCT00998933 | Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure | hypogonadism | Testosterone (NPC161423) | NP level |
NCT00515112 | Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer | prostate cancer | Testosterone (NPC161423) | NP level |
NCT00748059 | The Pathophysiology of Orthostatic Hypotension | orthostatic intolerance;orthostatic hypotension | Propranolol (NPC318591) | NP level |
NCT02974114 | Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain | pain | Caffeine (NPC256849) | NP level |
NCT00089843 | Bone Loss in Women With Anorexia Nervosa | anorexia nervosa | Testosterone (NPC161423) | NP level |
NCT02225093 | A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer | prostate cancer | Caffeine (NPC256849) | NP level |
NCT01386567 | A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 | hypogonadism | Testosterone (NPC161423) | NP level |
NCT03083431 | Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity | retinopathy of prematurity | Propranolol (NPC318591) | NP level |
NCT03049306 | Propranolol for Sleep Apnea Therapy | obstructive sleep apnea | Propranolol (NPC318591) | NP level |
NCT04504045 | Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Caffeine (NPC256849) | NP level |
NCT01699178 | Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men | hypogonadism | Testosterone (NPC161423) | NP level |
NCT02863575 | A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine | pain | Caffeine (NPC256849) | NP level |
NCT04921982 | Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD | post-traumatic stress disorder | Propranolol (NPC318591) | NP level |
NCT00443170 | A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects | anemia (phenotype) | Caffeine (NPC256849) | NP level |
NCT01999829 | Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo | atrial fibrillation | Caffeine (NPC256849) | NP level |
NCT00705796 | Influence of Administration Route of Testosterone on Male Fertility | hypogonadism | Testosterone (NPC161423) | NP level |
NCT04831099 | Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study | Genetic disorder of sex development | Testosterone (NPC161423) | NP level |
NCT00675714 | Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation | burn | Propranolol (NPC318591) | NP level |
NCT00564824 | The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease | coronary artery disease | Caffeine (NPC256849) | NP level |
NCT00744185 | Propranolol in Capillary Hemangiomas | hemangioma | Propranolol (NPC318591) | NP level |
NCT01578473 | Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease | Abnormality of connective tissue | Testosterone (NPC161423) | NP level |
NCT03768492 | Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy | breast carcinoma | Caffeine (NPC256849) | NP level |
NCT04643249 | Drug-drug Interaction Study of KL1333 in Healthy Subjects | mitochondrial disease | Caffeine (NPC256849) | NP level |
NCT02433730 | Testosterone Therapy in Hypogonadal Men Treated With Opioids | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01079715 | Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity | retinopathy of prematurity | Propranolol (NPC318591) | NP level |
NCT00236561 | A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine | Headache;migraine disorder | Propranolol (NPC318591) | NP level |
NCT01092858 | NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH) | hypogonadism | Testosterone (NPC161423) | NP level |
NCT01469988 | The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial | heart failure | Testosterone (NPC161423) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
SRC,PDGFRA,AR,CDK19,FLT3,ABL1,FGFR1,CDK8,KIT
|
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
SLC6A4
NCT00495092,NCT00733993,NCT01978457,NCT00688805,NCT01822587,NCT00830362,NCT00158132,NCT00000197 |
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
ADRB1,CACNA1C,RET,FOLR1,NR3C1,FGFR1,HTR2A,KIT,FLT1
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NR3C1,HTR2A,FGFR1,NR3C2,ADRB3,METAP2
NCT00432887,NCT04504045 |
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
CSF1R,ADRB2,FLT1,KDR,FGFR1,EGFR,FLT4,TYMS
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
KIT,FLT4,FLT1,KDR,EGFR,FOLR1,PDGFRB
NCT03323710 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
KDR,HTR2C,NR3C1,FGFR1,ADRB3,HTR2A,PDGFRB,ADRB1
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
RAF1,FOLR1,BRAF,FLT3,KDR,ARAF,SRC,FGFR1
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
MAPK14,SLC19A1,NR3C1,SLC46A1,DHFR
NCT01636557,NCT03131973,NCT04246762 |
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
AR,MAPK14,EPHX2,ADRB2,NR3C1,ADRB3
NCT00549120,NCT00687700 |
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT02183688,NCT02582996,NCT01629329,NCT03022838,NCT01248468,NCT01080677,NCT00772031,NCT00236561
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
DHFR,CSF1R,FLT3,HTR2C,HCK,HTR2A,EPHX2,FOLR2
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
ADRB1,RET,PDGFRB,PDGFRA,DDR2,HTR2B,FGFR1,HTR2A
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
AR,NR3C1,TYMS,DHFR,CYP19A1,HTR2C,FGFR1,KIT
|
Gonadotropin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A61.2 |
NCT00962637,NCT00647868,NCT00706719,NCT02149264,NCT00857168,NCT02111434,NCT01092858,NCT00663793,NCT02937740,NCT00244023,NCT02712944,NCT00254553,NCT02111473,NCT01228071,NCT01252745,NCT03203681,NCT01403116,NCT00161421,NCT00705796,NCT02433730,NCT04523480,NCT02722278,NCT02847806,NCT01786473,NCT02081300,NCT01386606,NCT01419236,NCT04492553,NCT00957528,NCT00522431,NCT04976595,NCT01993225,NCT01386567,NCT00345969,NCT01270841,NCT01370369,NCT00161486,NCT04439799,NCT02147964,NCT01323140,NCT00400335,NCT01699178,NCT00998933,NCT01887418,NCT00204269,NCT00304213,NCT01816295,NCT03198728,NCT00398580,NCT01127659,NCT01665599,NCT01446042,NCT03091348,NCT01893281,NCT00431197,NCT00857961,NCT03345797,NCT00433199,NCT04558567,NCT01993212,NCT00702650,NCT00857454,NCT03281187,NCT02419105,NCT02110368,NCT00372008,NCT04274894,NCT03118479,NCT01703741,NCT01133548
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
FGFR1,FLT3,SRC,ABL1,KIT,TEK,LCK
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MAPK1,MAPK3,CSF1R,EGFR,HTR2A,SRC,FLT1
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
EGFR,FLT4,KIT,MKNK2,PDGFRB,KDR,FGFR1
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
EPHX2,NR3C2,HTR2B,ADRB1,ADRB2,ADRB3
NCT01007994 |
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
KIT,PDGFRA,KDR,CDK6,EPHB4,EGFR,SRC
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
ADRB2,ADRB3,SERPINA6,NR3C1,ADRB1
NCT01074853,NCT01544634 |
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
SERPINA6,NR3C1,SRC,MAPK14,ABL1,LCK,KIT
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
LCK,ABL1,SRC,NR3C2,AR,HTR2A,KDR
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
PDGFRB,FGFR1,FLT1,RET,KIT,PDGFRA,KDR
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
TYMS,CYP19A1,HCK,TYMS,CSF1R,TSHR,FLT1
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
CSF1R,SHBG,FOLR2,CDK6,DDR2,HTR2C,KIT
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
TYMS,CYP19A1,FOLR1,HTR2C,SRC,TYMS,CYP19A1
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
CSNK1A1,ABL1,CSF1R,SRC,FLT3,HTR2C
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
KDR,EGFR,SLC6A4,FLT3,HTR2A
NCT00930306 |
Retinopathy of prematurityDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71.3 |
NCT02504944,NCT02014454,NCT01079715,NCT03038295,NCT01238471,NCT03083431
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
LCK,HCK,ADRB1,RET,PGR,FLT4
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT02051634
NCT00309855,NCT02203656,NCT02679274,NCT02990533 |
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
HTR2C,HTR2B,NR3C1,HTR2A,SLC6A4
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
NR3C1,HTR2C,SLC6A4
NCT00437632,NCT01634347 |
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
ADRB1,NR3C2,AR
NCT00957034,NCT01469988 |
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
HTR2C,HTR2A,SLC6A4,HTR2B
NCT03533556 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
SRC,NR3C1
NCT00405353,NCT02317263,NCT03000127 |
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
FLT3,ABL1,KIT,RET,TEK
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
SLC6A4,HTR2A,HTR2C
NCT02153944,NCT01784250 |
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
BRAF,ARAF,EGFR,KDR,RAF1
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NR3C2,HTR2A,AR
NCT02418065,NCT01087749 |
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
RAF1,FLT1,NR3C1,SERPINA6,TEK
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
FLT3,SLC46A1,PDGFRA,SLC19A1,SRC
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
SLC6A4
NCT01988883,NCT04186286,NCT00748059,NCT00223691 |
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT02740712,NCT01596647,NCT01517399,NCT02520752,NCT03333824
|
Burn and burn infectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND90-NE2Z |
NCT00673309,NCT01957449,NCT01902810,NCT00675714,NCT02452255
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
LCK,HCK,CSF1R,TSHR,FLT3
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
TYMS,CYP19A1,CDK6,SERPINA6,HTR2C
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
TYMS,SLC19A1,FOLR1,SERPINA6,HTR2C
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
TYMS,RET,TSHR,HTR2B,HTR2C
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
TYMS,RET,SERPINA6,HTR2C,SLC6A4
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
ADRB1,PGR,SLC6A4,KIT,ADRB2
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
ADRB3,HTR2A,ADRB1,ADRB2
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
HTR2C,AR,HTR2A,HTR2B
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
FOLR1,PGR,SRC,FGFR1
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
SLC6A4,HTR2C,CDK6,HTR2A
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
EGFR
NCT00356187,NCT01007084,NCT00069355 |
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
DHFR,NR3C1,RAF1,RET
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
NR3C1,NR3C1
NCT03556592,NCT02647086 |
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
FLT3,SRC,FGFR1,KDR
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
KIT,SRC,KDR,PDGFRA
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
FLT3,CDK6
NCT02397382,NCT02772601 |
Injury of spinal cord, level unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51.2 |
NCT02317640,NCT02323698,NCT01652040,NCT03345576
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
KIT,CDK8,CDK6
NCT00757185 |
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
FLT1,CYP19A1,RET,FLT4
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
SLC46A1,CSF1R,NR3C1,KDR,RAF1,SLC19A1,FOLR1,FLT3,ABL1,MAPK1,FGFR1,ARAF,GART,TYMS,CSNK1A1,RET,PDGFRB,KIT,BRAF,MAPK3,FLT1,LCK,METAP2,SRC,PGR,MKNK2,TEK,CDK6,PDGFRA,DHFR,EGFR,FLT4
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR,RET,KDR
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
SRC,ABL1,EGFR
|
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
SLC6A4,ADRB1,HTR2C
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
KIT,FLT3,PDGFRA
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
HTR2B,HTR2A,HTR2C
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
MAPK14
NCT00000493,NCT00000492 |
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3,KIT,CSF1R
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
SLC46A1,SLC19A1,ABL1
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
HTR2A,FGFR1,FLT3
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
KDR,PDGFRA,SRC
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
FLT1,TEK,FLT1
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
MAPK14,ADRB1,FGFR1
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
FGFR1,FLT1,DHFR
|
Functional bladder disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50 |
ADRB3,ADRB2,ADRB3
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
CSF1R,METAP2,RAF1
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3,KIT,CSF1R
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3,KIT,CSF1R
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
HTR2A,NR3C1,SLC6A4
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
NR3C1,CYP19A1,FGFR1
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00388128,NCT01797718,NCT00748059
|
Tension-type headacheDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A81 |
NCT00236561,NCT01755702,NCT01172405
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT00382057,NCT00438321,NCT00479609
|
Intracranial injury, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.Z |
NCT01202110,NCT05427474,NCT01322048
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TYMS,TSHR,HTR2C
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
RAF1,SRC,SLC19A1
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
HTR2C,SLC19A1,TYMS
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
HCK,FLT3,FLT1
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
HCK,RET,ADRB2
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
ATIC,CACNA1C,DHFR,SLC46A1,TEK,GART,ADRB3,PDGFRB,CCNC,CDK8,CDK6,EGFR,FGFR1,AR,SRC,PDGFRA,TSHR,METAP2,TYMS,ABL1,FOLR2,DDR2,HTR2B,KDR,FLT1
|
Sexual dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA00-HA01 |
HTR2A
NCT00612742,NCT00657501,NCT00698035,NCT00613002,NCT01096329,NCT00467259,NCT00349791,NCT00075855,NCT02101203,NCT00131495,NCT01743235,NCT00338312,NCT01235754,NCT01364623,NCT00331214,NCT01432665,NCT00331123,NCT00384046,NCT00140153 |
Circulatory system diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
ADRB1,FLT4
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
ADRB1,NR3C1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1,PGR
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
SRC,EGFR
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
EGFR,KDR
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
SRC,ABL1
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
AR,NR3C1
|
Sleep-wake disorderDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7B2Z |
HTR2A,HTR2C
|
Preterm labour/deliveryDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB00 |
ADRB2,PGR
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
NR3C1,CYP19A1
|
Hypo-osmolality/hyponatraemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C72 |
NR3C2,AR
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
SLC19A1,SLC46A1
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
HTR2A,SLC6A4
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
FLT1
NCT03609307 |
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
CSF1R,SRC
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
ADRB1,EGFR
|
Conduction disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC63 |
ADRB1,ADRB2
|
Vitamin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55-5B5F |
MAPK14,NR3C1
|
Supraventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81 |
ADRB2,ADRB1
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
KDR,SRC
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
ADRB3,EGFR
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
RET,EGFR
|
Chronic insomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00 |
HTR2C,HTR2A
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
PGR,AR
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MAPK1,MAPK3
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC,FGFR1
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
KDR,EGFR
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
NCT03339635 |
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
ADRB3
NCT01061190 |
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MKNK2,EGFR
|
Folate deficiency anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A02 |
SLC46A1,SLC19A1
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
NCT01205074,NCT01134692
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT02985671,NCT03364075
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT03238092,NCT03378713
|
AsphyxiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11.1 |
NCT03321734,NCT01875159
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000492,NCT00000493
|
Male erectile dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA01.1 |
NCT00244023,NCT00202163
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00413244,NCT00564824
|
Migraine without auraDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80.0 |
NCT00471952,NCT00884663
|
Migraine with auraDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80.1 |
NCT00884663,NCT00471952
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT02012777,NCT01077921
|
AngiosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B56 |
NCT04518124,NCT02732678
|
Age-associated cognitive declineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.0 |
NCT00889096,NCT05170464
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
RET
NCT03187496 |
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CSF1R,CDK6
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
FOLR1,HTR2C
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
TYMS,HTR2C
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
ADRB3,RET
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
CYP19A1,EGFR
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
HTR2A,SLC6A4
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
ATIC,DHFR,CSF1R,FLT3,SLC46A1,GART,LCK,CCNC,CDK6,EGFR,FOLR1,RET,HCK,SRC,SLC19A1,HTR2A,TYMS,FOLR2,KDR
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
ATIC,DHFR,HTR2C,GART,SLC6A4,LCK,CCNC,CDK6,FOLR1,RET,HCK,TSHR,SLC19A1,SERPINA6,TYMS,ADRB1,CYP19A1,FOLR2
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
TEK,FLT4,RET,MKNK2,EGFR,FGFR1,KDR,ABL1,PGR,SRC,NR3C1,AR,CDK6,ADRB2,CYP19A1
NCT01847001,NCT02596867 |
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
LCK,CSNK1A1,HCK,ADRB3,TYMS,CACNA1C,CSF1R,PGR,PDGFRB,FOLR2,DDR2,FOLR1,HTR2B,CDK19,TEK,HTR2A,KIT
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
CSF1R,HTR2C,HIPK2,TEK,GART,KIT,ADRB3,CDK6,FGFR1,RET,HCK,MAPK1,SLC19A1,SERPINA6,ARAF,FOLR2,KDR
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
PDGFRB,FGFR1,KIT,FLT1,FLT4,CACNA1C,FLT3,HTR2A,SLC6A4,HTR2C,KDR,MAPK14,CSF1R
NCT00726726,NCT04570085,NCT00692510 |
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
ATIC,DHFR,CSF1R,HTR2C,HIPK2,GART,LCK,CCNC,RET,HCK,TSHR,TYMS,ADRB1
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
KDR,FGFR1,FLT4,CDK6,EGFR,EPHB4,RAF1,RET,KIT,FLT3,PDGFRA,FOLR1
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
HTR2C,ADRB3,ADRB1,ADRB2,METAP2,SLC6A4
NCT00377975,NCT00302289,NCT02048215,NCT01160328,NCT05445232,NCT01616732 |
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
PDGFRB,PDGFRA,RET,SRC,KDR,FLT1,FGFR1,KIT,LCK,FLT3
NCT02420223 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
RAF1,HTR2A,SLC6A4,SRC,ADRB3,HTR2C,BRAF
NCT03970798,NCT00459420,NCT01738178,NCT01190735 |
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
ADRB2,ARAF,KDR,ADRB1,MAPK1,MAPK3,RAF1,BRAF,EGFR
NCT01705392,NCT02962947 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
FLT1,FGFR1,EGFR,FLT3,TYMS,KDR,MKNK2,RET,KIT
NCT00888797,NCT03919461 |
Post-traumatic stress disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B40 |
HTR2A
NCT01349439,NCT01713556,NCT00611871,NCT03151681,NCT04985344,NCT04982211,NCT00465608,NCT01127568,NCT04921982,NCT05189977 |
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NR3C1,AR,FLT4,SLC46A1,SLC19A1
NCT00577980,NCT00006044,NCT00587431,NCT03734653,NCT02225093,NCT00515112 |
HemangiomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E81-2F2Y |
NCT00967226,NCT01056341,NCT01074437,NCT00744185,NCT01072045,NCT01743885,NCT03237637,NCT01512173,NCT02342275,NCT02505971,NCT04684667
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
ATIC,TYMS,CACNA1C,ABL1,SRC,PDGFRB,MAPK3,FOLR1,CDK19,FGFR1,SLC6A4
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
LCK,AR,HCK,KDR,DHFR,CSF1R,PDGFRA,CYP19A1,TSHR,FOLR2,FOLR1
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
KDR,FGFR1,CDK8,CDK19,KIT,RET,EGFR,FLT1,PDGFRA,PDGFRB
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
SLC6A4,HTR2C
NCT04872270,NCT02511483,NCT01426971,NCT01842633,NCT02863575,NCT02862977,NCT04132336,NCT02974114 |
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
KIT,CACNA1C,PGR,SRC,PDGFRB,CYP19A1,CDK6,FOLR1,FGFR1,SLC6A4
|
Systemic inflammatory response syndrome of noninfectious originDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG46 |
NCT02051634
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
SRC
|
Metastatic meninges neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D51 |
EPHB4
|
Intrathoracic organs injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NB32 |
MAPK14
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
Uterine fibroidDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E86 |
PGR
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
DHFR
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
NR3C1
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
NR3C1
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
Adaptive immunity immunodeficiencyDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01 |
NR3C1
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
PDGFRA
|
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
SLC6A4
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
concerning food/fluid intake symptomDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG43 |
SLC6A4
|
Corneal diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A76-9A78 |
SLC6A4
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Spine/trunk injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51 |
NR3C1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1
|
Central and peripheral nervous diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8E7Z |
ADRB1
|
CachexiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG20 |
ADRB2
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
EGFR
|
Adrenocortical insufficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A74 |
NR3C2
|
Sleep-related breathing disorderDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A4Z |
ADRB2
|
Ventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC71 |
ADRB1
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
EGFR
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
|
AlopeciaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED70 |
AR
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
ADRB1
|
Cystic/dysplastic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB8Y |
EPHB4
|
Menstrual cycle bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20 |
PGR
|
Intracranial injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07 |
PDGFRB
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
SRC
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
EGFR
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
SLC6A4
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
AR
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
SERPINA6
|
Dystonic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A02 |
ADRB3
|
Cardiac arrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC9Z |
ADRB1
|
Abnormal micturitionDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF50 |
ADRB3
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
AR
|
ToxoplasmosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F57 |
DHFR
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
FOLR1
|
Mammary tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Z |
AR
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
HTR2A
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
DHFR
|
Adrenogenital disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A71 |
NR3C1
|
Malignant intestine neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C0Z |
KIT
|
Dermal/subcutaneous connective tissue atrophy/degenerationDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EE40 |
ADRB2
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
HTR2C
|
Prostate hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA90 |
AR
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AR
|
Testicular dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A81 |
AR
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
SLC6A4
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
HTR2A
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3
|
Menopausal disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30 |
SLC6A4
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
Ejaculatory dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA03 |
SLC6A4
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
DHFR
|
Heart beat abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC81 |
ABL1
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
ADRB2
|
Psychoactive substances use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4G |
HTR2C
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
DHFR
|
Alcoholic liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94 |
AR
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
HTR2A
|
Social anxiety disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B04 |
HTR2A
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
ADRB1
|
Neurobehavioral disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00-8A0Z |
SLC6A4
|
Metastatic tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E2Z |
EPHB4
|
Binge eating disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B82 |
SLC6A4
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
HTR2A
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NR3C1
|
CoughDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD12 |
SLC6A4
|
Muscle disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32-FB3Z |
AR
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
SLC6A4
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
ABL1
|
DysmenorrhoeaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34.3 |
NCT01462370
|
Obstructive sleep apnoeaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A41 |
NCT03049306
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00965341
|
Impairment of binocular functionsDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9D46 |
NCT02594358
|
Hereditary breast and ovarian cancer syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C65 |
NCT00080756
|
Insulin-resistance syndromesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A44 |
NCT02256865
|
Penile fibromatosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB06.2 |
NCT01578473
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
NCT03003000
|
Marfan syndrome or Marfan-related disordersDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD28.0 |
NCT00651235
|
Other specified inborn errors of energy metabolismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C53.Y |
NCT04643249
|
Syncope and collapse, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG45.Z |
NCT00093860
|
DyspareuniaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA12 |
NCT01697345
|
AnemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A00-3A9Z |
NCT00443170
|
Bacterial infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C41 |
NCT00513110
|
Cervical spine painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.0 |
NCT03003000
|
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT04265053
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NCT04005365
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT01265576
|
Oesophageal varicesDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA26.0 |
NCT01134692
|
Shoulder lesionDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB53 |
NCT02620579
|
Other specified disorders of musclesDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32.Y |
NCT00183040
|
Chronic widespread painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.01 |
NCT03029845
|
Fracture of neck of femur, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NC72.2Z |
NCT00345969
|
Disorders of muscles, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB3Z |
NCT02873559
|
DyspnoeaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11.5 |
NCT02311088
|
Alcohol dependenceDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40.2 |
NCT01289561
|
Hereditary haemorrhagic telangiectasiaDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA90.00 |
NCT04113187
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT03358706
|
Infection, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1H0Z |
NCT01275170
|
AscitesDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME04 |
NCT02649335
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT01263197
|
Other specified disorders of teeth and supporting structuresDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0A.Y |
NCT05485805
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT03768492
|
Portal hypertensionDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB98.7 |
NCT01000779
|
Voice disturbances, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MA82.Z |
NCT01435837
|
Cerebral cavernous malformationDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22.41 |
NCT03523650
|
OsteoporosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83.1 |
NCT02467400
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT04425902
|
Common cold disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SA60 |
NCT01686646
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT02655614
|
Sex development malformative disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2A |
NCT04831099
|
Hypoglycaemia without associated diabetesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A41 |
NCT03079921
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT00586898
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT03864042
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
NCT03358706
|
Anorexia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B80 |
NCT00089843
|
Alcohol beverageDisease Category: X.Extension CodesDisease ICD-11 Code: XM1A61 |
NCT03588754
|
Acute stress reactionDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QE84 |
NCT04982211
|
LymphoedemaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD93 |
NCT02595996
|
NarcolepsyDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A20 |
NCT02832336
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01525628
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT00000492
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT03838029
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT01462318
|
Panic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B01 |
NCT02631694
|
Postmenopausal osteoporosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH17Q9 |
NCT01058317
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT01999829
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT02871349
|
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT03161964
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT00006158
|
Supraventricular tachyarrhythmia, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.Z |
NCT00390546
|
HypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA20-BA21 |
NCT04580342
|
Ventricular fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC71.1 |
NCT00000492
|
MenopauseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30.0 |
NCT02445716
|
Malignant neoplasm metastasis in male genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E06 |
NCT05011383
|
Chronic lymphocytic leukaemia of B-cell typeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.00 |
DDR2
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
HTR2A
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
HTR2C
|
Intrauterine growth restrictionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA20.1 |
FLT1
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
FLT1
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
PDGFRB
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TYMS
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
SERPINA6
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CSF1R
|
Other specified diseases of the nervous systemDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E7Y |
HIPK2
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
HIPK2
|